PEspeaks

May 01, 2015
Watching the latest volleys fly in the ongoing specialty drug pricing wars, Tom Norton wonders: Is it possible that all involved couldn’t just step back and take a breath?
Apr 30, 2015
Neuroscience luminaries clamored onto the stage at this week's World Medical Innovation Forum in Boston to present the meeting’s much-anticipated "Disruptive Dozen".
Apr 30, 2015
The revised Cures proposal makes it easier for pharma to distribute journal articles and medical textbooks to physicians, but it also drops provisions that provided added exclusivity for certain new therapies.
Apr 29, 2015
Pricing and Sovaldi couldn’t avoid mention at this week’s World Medical Innovation Forum put on by Partners Healthcare in Boston. The meeting highlighted multiple issues in neuroscience but also touched on hot buttons across the industry.
Apr 26, 2015
The industry continues to puzzle over FDA's proposed regulation of mobile medical apps (MMAs), writes Jill Wechsler.
Apr 22, 2015
Regarding this week’s Teva/Mylan/Perrigo news, early postures point to a drawn out affair, writes Casey McDonald.
Pharmaceutical Executive: Apr 20, 2015
The task of imitating substantially complex molecular entities offers up a host of new operational questions for pharma, writes Casey McDonald.
Apr 19, 2015
Reflector edges through the complex terrain that is health technology assessment in Europe.
Apr 16, 2015
Sunshine was a strong feature of this week's CBI’s Global Transparency Reporting Congress in London, in more ways than one.
Apr 15, 2015
Leela Barham looks at what the rival parties are promising for healthcare ahead of the UK General Election next month.